DARE offering history
Every offering-related filing in Dare Bioscience, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 759 filings back to May 29, 2007.
| Date | Filing | What it means | |
|---|---|---|---|
| May 18, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 7, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 20, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 13, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 17, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 9, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 29, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 26, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 26, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 15, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Oct 21, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 10, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 10, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 1, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 1, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 29, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 29, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 28, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 26, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 30, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 31, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 13, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 8, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 7, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 30, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 22, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 7, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 7, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 5, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 23, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 22, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Sep 11, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 15, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 8, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 8, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 20, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 15, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 12, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 12, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 1, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
DARE offering FAQ
When did DARE last execute an offering?
Per SEC filings, Dare Bioscience, Inc.'s most recent priced offering document is a 8-K filed 2026-05-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did DARE last announce or register an offering?
The most recent registration is a S-1 filed 2024-11-15. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.